Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TULP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF827 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR9LP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RAB40C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEMGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BID - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST20-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM26-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD45C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF431 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR7113 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on